C1019T polymorphism in the connexin 37 gene and myocardial infarction risk in premature coronary artery disease

Journal of Tehran University Heart Center

Volumn 12, Issue 2, 2017, Pages 72-81

  Sheikhvatan, Mehrdad ^a   Ali Boroumand, Mohammad ^a   Behmanesh, Mehrdad ^b   Abbasi, Seyed Hesameddin ^a   Davoodi, Gholamreza ^a   Ziaee, Shayan ^a   Cheraghi, Sara ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Connexin 37; Genes; Genetic; Myocardial infarction; Polymorphism

Indexed keywords

CONNEXIN 37;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GJA4 GENE; HEART INFARCTION; HETEROZYGOTE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; IRANIAN PEOPLE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85015742944     PISSN: 17358620     EISSN: 20082371     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report from the American Heart Association. Circulation 2016;133: e38-360.
2. Rissanen AM. Familial occurrence of coronary heart disease: effect of age at diagnosis. Am J Cardiol 1979;44: 60-66.
3. Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, Anand S, Engert JC, Samani NJ, Schunkert H, Erdmann J, Reilly MP, Rader DJ, Morgan T, Spertus JA, Stoll M, Girelli D, McKeown PP, Patterson CC, Siscovick DS, O’Donnell CJ, Elosua R, Peltonen L, Salomaa V, Schwartz SM, Melander O, Altshuler D, Ardissino D, Merlini PA, Berzuini C, Bernardinelli L, Peyvandi F, Tubaro M, Celli P, Ferrario M, Fetiveau R, Marziliano N, Casari G, Galli M, Ribichini F, Rossi M, Bernardi F, Zonzin P, Piazza A, Mannucci PM, Schwartz SM, Siscovick DS, Yee J, Friedlander Y, Elosua R, Marrugat J, Lucas G, Subirana I, Sala J, Ramos R, Kathiresan S, Meigs JB, Williams G, Nathan DM, MacRae CA, O’Donnell CJ, Salomaa V, Havulinna AS, Peltonen L, Melander O, Berglund G, Voight BF, Kathiresan S, Hirschhorn JN, Asselta R, Duga S, Spreafico M, Musunuru K, Daly MJ, Purcell S, Voight BF, Purcell S, Nemesh J, Korn JM, McCarroll SA, Schwartz SM, Yee J, Kathiresan S, Lucas G, Subirana I, Elosua R, Surti A, Guiducci C, Gianniny L, Mirel D, Parkin M, Burtt N, Gabriel SB, Samani NJ, Thompson JR, Braund PS, Wright BJ, Balmforth AJ, Ball SG, Hall A; Wellcome Trust Case Control Consortium, Schunkert H, Erdmann J, Linsel-Nitschke P, Lieb W, Ziegler A, König I, Hengstenberg C, Fischer M, Stark K, Grosshennig A, Preuss M, Wichmann HE, Schreiber S, Schunkert H, Samani NJ, Erdmann J, Ouwehand W, Hengstenberg C, Deloukas P, Scholz M, Cambien F, Reilly MP, Li M, Chen Z, Wilensky R, Matthai W, Qasim A, Hakonarson HH, Devaney J, Burnett MS, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Knouff CW, Waterworth DM, Walker MC, Mooser V, Epstein SE, Rader DJ, Scheffold T, Berger K, Stoll M, Huge A, Girelli D, Martinelli N, Olivieri O, Corrocher R, Morgan T, Spertus JA, McKeown P, Patterson CC, Schunkert H, Erdmann E, Linsel-Nitschke P, Lieb W, Ziegler A, König IR, Hengstenberg C, Fischer M, Stark K, Grosshennig A, Preuss M, Wichmann HE, Schreiber S, Hólm H, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Engert JC, Do R, Xie C, Anand S, Kathiresan S, Ardissino D, Mannucci PM, Siscovick D, O’Donnell CJ, Samani NJ, Melander O, Elosua R, Peltonen L, Salomaa V, Schwartz SM, Altshuler D. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009;41: 334-341.
4. Cipriani V, Mannucci PM, Ardissino D, Ferrario M, Corsini G, Merlini PA, Notarangelo F, Lina D, Bernardinelli L. Familial aggregation of early-onset myocardial infarction. Eur J Intern Med 2010;21: 511-515.
5. Brown DW, Giles WH, Burke W, Greenlund KJ, Croft JB. Familial aggregation of early-onset myocardial infarction. Community Genet 2002;5: 232-238.
6. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yokota M. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003;42: 1429-1437.
7. Boerma M, Forsberg L, Van Zeijl L, Morgenstern R, De Faire U, Lemne C, Erlinge D, Thulin T, Hong Y, Cotgreave IA. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999;246: 211-218.
8. Incalcaterra E, Caruso M, Balistreri CR, Candore G, Lo Presti R, Hoffmann E, Caimi G. Role of genetic polymorphisms in myocardial infarction at young age. Clin Hemorheol Microcirc 2010;46: 291-298.
9. Collings A, Raitakari OT, Juonala M, Mansikkaniemi K, Kähönen M, Hutri-Kähönen N, Marniemi J, Viikari JS, Lehtimäki TJ. The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism - The Cardiovascular Risk in Young Finns Study. Clin Chem Lab Med 2008;46: 1102-1108.
10. Han YL, Xi SY, Zhang XL, Yan CH, Yang Y, Kang J. Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population. Zhonghua Yi Xue Za Zhi 2007;87: 100-104.
11. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis 2007;191: 355-361.
12. Maleki A, Shariari A, Sadeghi M, Rashidi N, Alyari F, Forughi S, Nabatchi B, Ghanavati R. Evaluation of fibrinolytic medical therapy for patients with acute myocardial infarction. ARYA Atheroscler 2012;8: 46-49.
13. Gharipour M, Khosravi A, Sadeghi M, Roohafza H, Hashemi M, Sarrafzadegan N. Socioeconomic characteristics and controlled hypertension: evidence from Isfahan Healthy Heart Program. ARYA Atheroscler 2013;9: 77-81.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16: 1215.
15. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;347: 1916-1923.
16. Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL. Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans. J Am Coll Cardiol 2004;44: 165-167.
17. Listì F, Candore G, Lio D, Russo M, Colonna-Romano G, Caruso M, Hoffmann E, Caruso C. Association between C1019T polymorphism of connexin37 and acute myocardial infarction: A study in patients from Sicily. Int J Cardiol 2005;102: 269-271.
18. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis 2007;191: 355-3561.
19. Collings A, Islam MS, Juonala M, Rontu R, Kähönen M, Hutri-Kähönen N, Laitinen T, Marniemi J, Viikari JS, Raitakari OT, Lehtimäki TJ. Associations between connexin37 gene polymorphism and markers of subclinical atherosclerosis: The Cardiovascular Risk in Young Finns study. Atherosclerosis 2007;195: 379-84.
20. Seifi M, Fallah S, Ghasemi A, Aghajani H, Razaghi M, Danaei N. Mutations of the connexin 37 and 40 gap-junction genes in patients with acute myocardial infarction. Clin Lab 2013;59: 343-348.
21. Balatskiĭ AV, Andreenko EY, Samokhodskaya LM, Boĭtsov SA, Tkachuk VA. Endothelial NO synthase and connexin 37 gene polymorphisms as a risk factor for myocardial infarction in subjects without a history of coronary artery disease. Ter Arkh 2013;85: 18-22.
22. Li BS, Wang XY, Ma FL, Jiang B, Song XX, Xu AG. Is high resolution melting analysis (HRMA) accurate for detection of human disease-associated mutations? A meta-analysis. PLoS One 2011;6: e28078.
23. Wittwer CT. High-resolution DNA melting analysis: Advancements and limitations. Hum Mutat 2009;30: 857-859.
24. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, Goodenough DA, Kwak BR. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006;12: 950-954.
25. Li Z, Smyth SS. Connexin 37 counteracts clotting. Circulation 2011;124: 873-875.
26. Angelillo-Scherrer A, Fontana P, Burnier L, Roth I, Sugamele R, Brisset A, Morel S, Nolli S, Sutter E, Chassot A, Capron C, Borgel D, Saller F, Chanson M, Kwak BR. Connexin 37 limits thrombus propensity by downregulating platelet reactivity. Circulation 2011;124: 930-939.
27. Yeh HI, Chang HM, Lu WW, Lee YN, Ko YS, Severs NJ, Tsai CH. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem2000;48: 1377-1389.